Heads up: will the FTSE 100’s British American Tobacco be the next defensive stock to rebound?

I reckon British American Tobacco plc’s (LON: BATS) fat dividend tops off the firm’s defensive attractions.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Hunting for defensive firms that haven’t rebounded lately is challenging, but I think I’ve found a good candidate in smoking-focused consumer goods firm and Footsie constituent British American Tobacco (LSE: BATS).

At today’s share price around 3,764p, the stock is down more than 30% from its peak last June and looks like it has been caught up in an investor rotation out of expensive-looking defensive firms and into cheaper-looking cyclicals. But unlike some other defensive firms such as Imperial Brands, DiageoGlaxoSmithKline, National Grid, SSE and Unilever, BATS has yet to participate in the bounce-back of these stocks we’ve seen this year so far. Maybe the firm’s time in the sun will arrive soon.

Big borrowings

However, there could be company-specific issues holding the stock down. For example, last July’s almost £42bn acquisition of US peer Reynolds American pushed the firm’s debt up to eye-popping levels. February’s full-year results revealed borrowings had jumped to £44bn, up from £16bn the year before, which means borrowings now are close to seven times the level of last year’s operating profit. We still need a full year of trading with Reynolds American in the fold to get an accurate picture of how debt relates to profits, but historically the stock market has often been kinder to acquired companies than those that do the acquiring. It will take time before we know how well BATS is integrating Reynolds American and how much the move will shift the dial on profits, meanwhile, the stock market hates uncertainty.

City analysts following the company expect earnings of the enlarged business to lift 5% this year and 8% next year. If those predictions prove accurate, BATS will still be moving in the right direction. Meanwhile, the dividend looks even more attractive than it has for some time. The forward yield runs at 5.8% for 2019 and those forward earnings should cover the payment almost one-and-a-half times. One of the great features of the firm’s business is its steady, predictable and rising cash flow, driven by smokers that return over and over again to repeat purchase. The reliability of cash flow justifies high debt loads for defensive companies and in BATS’ case, keeps the dividend moving up year after year. I don’t think those characteristics have changed following the Reynolds American acquisition.

Emerging next-generation products

In April with the annual general meeting statement, the firm said: “An unprecedented confluence of technology, consumer demand, societal change and public health awareness has created a unique opportunity.” Indeed, the company’s long-term future seems to be all about weening its customers off traditional tobacco products and onto less-harmful, smokeless Next-Generation Products, such as those used for vaping, tobacco heating, oral methods of taking tobacco, and nicotine-packed items like snus and moist snuff. By the end of 2018, the firm hopes to more than double its revenue from Next Generation Products to over £1bn. However, despite such progress, the directors expect combustible products to remain at the core of our business for “many years to come.”

I think British American Tobacco retains its defensive credentials and see the dividend yield as ‘attractive’ and worth collecting while I wait for share-price appreciation from here.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold owns shares in SSE. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended Diageo. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »